Table 1 Patients’ clinical characteristics
Parameters | All patients | P-value | Matched patients | P-value | ||
|---|---|---|---|---|---|---|
One stage (n = 84) | Two stage (n = 72) | One stage (n = 48) | Two stage (n = 48) | |||
Age, y | 57.76 ± 10.35 | 59.17 ± 9.8 | 0.388 | 56.88 ± 10.49 | 57.78 ± 10.59 | 0.676 |
Gender | 0.508 | 1.000 | ||||
Male | 25(29.8) | 25(34.7) | 15(31.3) | 14(29.2) | ||
Female | 59(70.2) | 47(65.3) | 33(68.8) | 34(70.8) | ||
BMI | 24.32 ± 2.97 | 24.00 ± 2.97 | 0.532 | 23.70 ± 2.92 | 23.89 ± 3.13 | 0.771 |
Smoking history | 0.514 | 1.000 | ||||
Yes | 13(15.5) | 14(19.4) | 6(12.5) | 7(14.6) | ||
No | 71(84.5) | 58(80.5) | 42(87.5) | 41(85.4) | ||
FEV1% Pred (mean,%) | 99.26 ± 13.39 | 95.05 ± 12.67 | 0.046 | 97.73 ± 13.88 | 95.27 ± 12.35 | 0.329 |
ppoFEV1% (mean,%) | 85.08 ± 11.47 | 75.60 ± 12.86 | <0.001 | 83.24 ± 12.20 | 78.58 ± 12.09 | 0.063 |
CCI score (median) | 3(2–3) | 3(2–4) | 0.387 | 3(2–3) | 3(2–4) | 0.678 |
ASA grade | 0.006 | 0.201 | ||||
1 | 65(77.4) | 40(55.5) | 37(77.1) | 34(70.8) | ||
2 | 15(17.9) | 26(36.1) | 9(18.8) | 14(29.2) | ||
3 | 2(2.4) | 6(8.3) | 2(4.2) | 0 | ||
Surgical procedure | 0.027 | 1.000 | ||||
Lobar + Lobar | 0 | 3 | 0 | 0 | ||
Lobar + Sublobar | 32 | 37 | 22 | 21 | ||
Sublobar + Sublobar | 52 | 32 | 26 | 27 | ||
Size of the largest tumor(cm) | 1.60 ± 0.90 | 1.70 ± 1.06 | 0.489 | 1.60 ± 0.66 | 1.67 ± 1.14 | 0.727 |